fda glp-1 warning letters september 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading September 15, 2025: Telehealth company
Description
GLP-1 gallbladder risk is gaining attention in 2026
Enhanced GLP-1 targets your bodys natural appetite pathway the same GLP-1 system that prescription drugs manipulate using eight plant-based, clinically studied ingredients
Powered by data from Ro's nationwide platform, the research will evaluate the real-world challenges that patients and providers must navigate in order to access and deliver evidence-based obesity care.
Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o
Can you take ibuprofen with Rybelsus
The surge in demand for GLP-1 medications for weight loss has shifted how healthcare providers approach weight management conversations.
